Skip to content
  • For institutional investors in the UK Change
  • Contact us
search bar
Janus Henderson Investors
  • About us
        • About Janus Henderson Investors

        • Our people

        • Environmental, Social and Governance (ESG)

        • Diversity, Equity and Inclusion

        • Who we are
        • Our investment capabilities
        • Connecting with our clients
        • About Janus Henderson Investors info-graphic
        • We provide access to some of the industry’s most talented and innovative thinkers.

          Meet our teams
        • Find out how environmental, social and governance (ESG) considerations are embedded within our organization and investment principles.

          Learn more
        • See how diversity, equity & inclusion are valued and supported at Janus Henderson.


          Learn more
        • About us
        • Our people
        • Diversity, Equity and Inclusion
        • Environmental, social and governance (ESG)
  • Defined Contribution
  • Insights
        • Explore insights

        • Analysis & studies
        • Features & outlooks
        • Timely & topical
        • View all insights
        • Market GPS

          2023 Investment Outlook:
          Finding the silver lining

          Explore
          GPS Map
        • Market GPS

          2023 Investment Outlook:
          Finding the silver lining

          Explore
          GPS Map
        • Analysis & studies
        • Features & outlooks
        • Timely & topical
        • View all insights
  • Client reporting
    • Institutional online client reporting
    • Secured credit reporting
    • Portfolio Turnover Report
  • Capabilities
    • Equity
    • Fixed Income
    • Alternatives
    • Multi-asset
{{banner.link_text}}
For institutional investors in the UK

Daniel Lyons, PhD, CFA

Portfolio Manager | Research Analyst
Daniel Lyons, Ph.D., CFA | Janus Henderson Investors

Daniel Lyons is a Portfolio Manager and Research Analyst at Janus Henderson Investors responsible for co-managing the Biotechnology strategy since 2018. Daniel started consulting for Janus in 1997 and joined the Health Care Sector Research Team full time in 2000. As a research analyst, he focuses on the biotechnology and life science tools sectors.

Daniel received his bachelor of arts degree in biochemistry and chemistry from Rice University, graduating magna cum laude. He also earned a PhD from Stanford University’s programme in immunology and conducted postdoctoral research with a Nobel Laureate at the University of Colorado. He holds the Chartered Financial Analyst designation and has 23 years of financial industry experience.

Products Managed
  • Global Life Sciences

Articles Written

Investing through the ups and downs of biopharma research
27 Jul 2022

Investing through the ups and downs of biopharma research

The biopharmaceutical industry often moves to the beat of its own drummer, creating opportunities for diversification.

Listen Now

  • United Kingdom
  • Institutional
  • Financial professionals
  • Individual investors
  • Investor relations
  • Media centre
  • Careers
  • Contact us
  • Legal Information
  • Privacy policy
  • Cookie policy
  • Fraud and security information
  • Modern slavery statement
  • Value Assessment Report
  • LinkedIn

Legal information | Privacy policy | Cookie policy | Security information

 

Cookies: The Janus Henderson Investors website uses cookies to remember your preferences and to help us to improve the site through the use of web analytics. By continuing without changing your cookie settings we will assume that you are happy to receive cookies for these two purposes. For full details on how to manage our cookies and how we use them, please see our cookie policy.

 

Marketing Communication. This website is intended solely for the use of institutional investors and consultants and is not for general public distribution. The value of an investment and the income from it can fall as well as rise and you may not get back the amount originally invested.

 

There is no assurance that the investment process will consistently lead to successful investing. Any risk management process discussed includes an effort to monitor and manage risk, which should not be confused with, and does not imply, low risk or the ability to control certain risk factors. The availability of our services and vehicles is subject to applicable laws, which may differ from one jurisdiction to another.

 

Issued in the UK by Janus Henderson Investors. Janus Henderson Investors is the name under which investment products and services are provided by Janus Henderson Investors International Limited (reg no. 3594615), Janus Henderson Investors UK Limited (reg. no. 906355), Janus Henderson Fund Management UK Limited (reg. no. 2678531), Henderson Equity Partners Limited (reg. no.2606646), (each registered in England and Wales at 201 Bishopsgate, London EC2M 3AE and regulated by the Financial Conduct Authority) and Janus Henderson Investors Europe S.A. (reg no. B22848 at 2 Rue de Bitbourg, L-1273, Luxembourg and regulated by the Commission de Surveillance du Secteur Financier).

 

We may record telephone calls for our mutual protection, to improve customer service and for regulatory record keeping purposes.

 

Janus Henderson, Knowledge Shared and Knowledge Labs are trademarks of Janus Henderson Group plc or one of its subsidiaries. © Janus Henderson Group plc.

 

Unless otherwise stated all data is sourced from Janus Henderson Investors.
 

Close Notification
TOP
You are now leaving janushenderson.com

You are now leaving our site and entering a website not operated by or affiliated with Janus Henderson Investors. While we aim to point you to useful external websites, we cannot be responsible for their content, opinions, advice or accuracy, even if you utilise the services on the linked site to invest in our products.

The protection of your personal information on other websites is not governed by Janus Henderson Investors privacy policy and Janus Henderson Investors cannot be responsible for the privacy policies utilised on such third party sites, nor for the implementation of such policies by those third parties.

You should review the Terms and Conditions of third party websites and contact the operators of such sites if you have any queries.

You are now leaving Janus Henderson's website and will be redirected to the website of the Securities and Exchange Commission (the "SEC"). Money market funds are required to provide the SEC with a monthly electronic filing of more detailed portfolio holdings information on Form N-MFP.

Janus Henderson is not responsible for the content, accuracy or timeliness and does not make any warranties, express or implied, with regard to the information obtained from other websites. This link should not be construed as either a recommendation or offer to by or sell any securities.

Region

Country

Language

What type of investor are you?